chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After 3 days, experienced nausea, fatigue and migraine; After 3 days, experienced nausea, fatigue and migraine; After 3 days, experienced nausea, fatigue and migraine; After vaccination, experienced arm pain that felt like it was ran over by a bulldozer; This is a spontaneous report received from non-contactable reporter(s) (Pharmacist). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 27Mar2021 (Lot number: ER8733) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "After vaccination, experienced arm pain that felt like it was ran over by a bulldozer"; NAUSEA (non-serious), FATIGUE (non-serious), MIGRAINE (non-serious) all with onset 30Mar2021, outcome "unknown" and all described as "After 3 days, experienced nausea, fatigue and migraine".  Additional information: The events were reported to patient by friend (withheld) (consumer) who personally sent a message in Facebook messenger. The patient recently was vaccinated with BNT162B2.   No follow-up attempts are possible. No further information is expected.
Redness et swelling at site redness 30mm x 40mm pink 6" x 5".
I went to the hospital the next day with sever pain throughout my body. I went home from the hospital and all that was done was they gave me pain medication. I was also having trouble regulating my body temperature. I went back to the hospital and they didn't think anything was wrong. I was sent home and eventually I started to get better. Then, months later that my symptoms came back, but they were much worse. My heart rate was elevated and I had Sinus Tachycardia. The doctors basically can't figure out what is gong on with me. I am also experiencing bouts of extreme cranial pressure.
Fever, chills, sore arm (cannot lift 10 pounds), swollen arm, missed day of work 3/7/19.
This spontaneous report as received from a nurse via a company representative refers to approximate 270 (reported as "90-93 percent of 300") patients of unknown age and gender. The company representative reported that these patients who were assumed to received the M-M-R II (lot#, dose, route not reported) were infected with mumps. Outcome of the event was unknown. This is one of several reports received from the same reporter. Additional information is not expected.
Client c/o burning at the site.  When EMT approached client refused to be assessed and stated that she was OK and did not feel any need for them.  Client advised to contact PCP or go to the ER if symptoms worsen.
Information has been received from a pharmacist referring to 2 newborns. Background: Since June 2015, there had been 1645 times (30 minutes each time= 822.5 hours) that the temperature dropped below 36F. Of course, there was 144 times (30 minutes each time=72 hours) that temperature was below 32F, the lowest being 29.7F. On 04-JUL-2015, there was a low temperature of 30.2F. On 27-JUL-2015 the patients were vaccinated with the improperly stored RECOMBIVAX HB strength 2.5/0.5 (units not provided) (lot number K020216 and expiration date of 17-SEP-2016) (dose and route of administration were not reported). There was no product quality complaint (PQC). This is one of several reports received from the same reporter. Additional information has been requested.
I had Covid to for awhile. I just got over it; I had Covid to for awhile. I just got over it; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (005570). The reporter is the patient.  A 74-year-old patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "recovered" and all described as "I had Covid to for awhile. I just got over it". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: I had Covid to for awhile. I just got over it.  Clinical course: Patient called to check on Premarin cream re enrolment and order status. During call patient stated how much going on I had Covid to for awhile. I just got over it. I had the booster shots and this and that and whatever you still get it.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pt recv vax & woke up Saturday w/ red throat, sneezing, coughing, runny eyes, nose;by Sunday went into chest;had to use machine many months;was sick about 1wk;
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Abdominal Pain-Medium, Systemic: Diarrhea-Medium, Additional Details: PATIENT SAID SHE IS HAVING SOME REDNESS ,AND SWELLING  AT INJECTION SITE ,ALONG LOW STOMACH ACHE AND MILD  DIARRHEA
This case was reported by a medical assistant and described the occurrence of aseptic cellulitis in a 4 year old female subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. The subject had no pre-existing medical conditions. There were no concurrent medications. On 2/7/06 the subject received 5th dose of Infanrix in the left arm (lot AC14A007AA). On 2/7/06, the subject also received injections of inactivated poliomyelitis virus vaccine (lot Y0824-2), and live MMR (lot 0293R). The injection site for IPOL and MMR II were not reported. On 2/9/06, two days after vaccination with Infanrix, the subject experienced aseptic cellulitis, which was described as a local reaction, a swollen left arm the size of a palm that was pink and non-tender. The subject was seen at a physician's office. The subject was treated with ice and rubbing of the area. The events resolved on 2/10/06. The medical assistant considered the events to be related to vaccination with Infanrix. Comment: Cellulitis was assessed as medically serious (OMIC).
6.5 hours after DTaP administration had 15 second rhythmic movements of bilateral upper extremities. Seen in ER at Hospital, normal exam, discharged with neurology follow up.
I had a metallic taste in my mouth for about 5 days after the second dose of Pfizer vaccine. More specifically towards the back of my throat; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 07May2021 at 09:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included lyme disease since unknown date. The patient had no known allergies. Concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 16Apr2021 at 09:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient not been tested positive for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 08May2021 the patient felt metallic taste in mouth for about 5 days more specifically towards the back of throat. This did not affect taste, and it did not involve the tongue or gums. It seems to have started wearing off after 5 days or so. On 10May2021, the patient underwent COVID-19 virus test (Curative) and the results was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported event.  The clinical outcome of the event metallic taste in mouth for about 5 days more specifically towards the back of throat was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
the day p/ vax pt exp fever 101-102 degrees & 8 lesions in mouth. addl info requested
I had the vaccine and later that night I  lost sensation in the tip of my right index finger about half a centimeter of my finger. I could not feel anything there. I could only feel extreme tingling the next day and ultra sensitive of pinching needles. And a couple of days later it became numb. And for my second dose I notified the medical personal about my adverse event and they did a medical test with a paper clip and I could feel that.
Rash developed on injection site arm below actual injection area, 7 days post injection. Started as quarter sized area with raised burning/itchy bumps, red and warm to the touch. Coverage area slowly grew throughout the day and became swollen. Day 2 area of rash was a good portion of outer bicep area, accompanied with fever, chills and aches. Fever, chills and aches subsided in 24 hours. Red, itchy, swollen rash continued to spread so that on day 3 it covered most of upper arm, wrapping all the way around. Today is day 4 and swelling is subsiding but redness & itch are still present and it still slowly spreading a little. May contact my pcp today
? Cellulitis - line drawn (L) shoulder, skin reddened, induration 4" x 3" on 1-11-08. Rechecked on 1-12-08, much improved.
At approximately 0730 I awoke with severe shivering. I was not running a fever, my 02 saturation was 14% and my heart rate was at 38. My lips were blue. My husband set me up a nebulizer treatment and my oxygen level slowly began returning to normal, as did my heart rate. It took approximately 1.5 to 2 hours to see my vitals return to normal. Now, if I fall asleep, my oxygen level begins to drop again drastically.
PATIENT'S MOTHER STATED AND SIGNED WAIVER THAT THE PATIENT WAS 12 YEARS OLD.  HOWEVER, IMMUNIZATION REGISTRY SITE HAS PATIENT LISTED AS ONLY BEING 11 YEARS OLD.  THIS WAS FOUND AFTER THE VACCINATION WAS GIVEN AND THE RECORD WAS BEING ENTERED.  THE FIRST DOSE WAS GIVEN BY ANOTHER PHARMACY
Pt broke out in hives on arms, neck, chest, and abdomen.  Pt reported to PCP who prescribed a MEDROL dose pack & topical BENADRYL.
DELAYED REACTION STARTING ON 3/25/21 (VACCINE RECEIVED 3/19)- PATIENT HAD NO NOTICABLE SIDE EFFECTS/SYMPTOM UNTIL 3/25/21. SWOLLEN GOLF-BALL SIZED KNOB ON ARM 2 INCHES BELOW VACCINE SITE THAT WAS RED IN COLOR AND HOT TO THE TOUCH. AS THE DAY PROGRESSED KNOB SUBSIDED BUT AREA OF REDNESS INCREASED FOR 2INCH DIAMETER TO 3 INCHS. COLOR HAS ALSO PROGRESSED FROM RED TO A DULL PURPLE.
short of breath, cough beginning around 11/18/21, then presented to ER and tested positive for covid
rash-itching, swollen eyes, swollen gland in neck;rash-raised welts-entire body rash lasted 3 days;APAP PM helped;
Fever of 2-3 degrees higher than normal Minor achiness Loss of appetite Loss of energy
PATIENT WAS SCARED TO RECEIVE VACCINATIONS. CRYING DURING ADMINISTRATION. PATIENT FELT LIGHTHEADED AFTER ADMINISTRATION OF VACCINES. SHE LAID DOWN ON EXAM TABLE FOR 5 MINUTES. BP LAYING DOWN 112/59, STANDING UP 106/64.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Sep-2021 at 2:58 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 24-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that on 24-Sep-2021, patient received the Moderna vaccine which expired on 22-Sep-2021. The patient did not have any adverse events and did not required any medical attention. No problems were reported from the patient.  No concomitant medication was reported.  No treatment information was reported.
Pt received Moderna (1st dose) on 6/7/2021 and received Pfizer (2nd dose) on 7/6/2021. Pt had no allergic or adverse reaction. Pt was notified at time of even and mandatory reporting done through Kaiser reporting system.
Fever, chills, severe body aches, cold sweat. Treated with advil and tylenol, lasted 36 hours. Sore arm, 4 days and not better yet
8/18/21 Injection site swollen and uncomfortable. Rt middle and  ring finger with small raised vesicle and itching.  8/19/21  Injection site swollen Rt ring and middle finger now swollen as well as vesicles and itching. 8/20/21 L arm with hive looking blotches on upper arm. Rt ring, index and middle fingers swollen and itching. 8/21/21 L arm at elbow another hive looking area and itching. 8/23/21 All of the above and now 3 hive like areas on foot.
patient in allergy clinic reporting persistent urticaria for six weeks since receiving second dose of vaccination. Symptoms started 36 hours after vaccination predominantly on arms and trunk. Patient went to urgent care and received dexamethasone with symptom resolution within a few hours. The next day symptoms returned and patient was prescribed oral methylprednisolone.  Symptoms returned and patient was prescribed prednisone. Patient has also been taking cetirizine and famotidine. Patient advise to continue antihistamines, initiated another course of prednisone, and will follow-up with allergy clinic.
Left arm red, swollen, warm to touch; began evening post injection. Reported to clinic 10/09; arm edematous elbow to shoulder, pain 10/7 to shoulder. Limited range of motion. 90 degree flexor; listed prior to incident. The discharge summary states cellulitis.
No additional AE details; incomplete dose of PEDVAX HIB was administered; a needle was not fully attached and squirted out during administration; This spontaneous report was received from a medical assistant and refers to a patient of unspecified age and gender. There was no information regarding the patient's medical history, concurrent condition and concomitant therapies details.  On 29-DEC-2022, the patient was vaccinated with haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, lot #W015927, expiration date: 15-FEB-2025, administered for prophylaxis (strength, and route of administration were not provided). The reporter stated that incomplete dose of vaccine was administered (Incorrect dose administered) after a needle was not fully attached and squirted out during administration (Product administration error). No product quality complaint was reported since needle and syringe was not a company product. No additional adverse event was reported.
Slightly sore arm; This is a spontaneous report from a contactable consumer. This 72-Year-old female consumer (Patient) reported that she received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine; Solution for injection; Lot number/expiry date: unknown) via an unspecified route of administration in the left arm as a single dose for COVID-19 immunization on 19Feb2021 at 01:15 PM. The patient's historical vaccine included the first dose of (Pfizer-BioNTech COVID-19 Vaccine; Solution for injection; Lot number/expiry date: unknown) in the left arm on 28Jan2021 at 12:00 PM. The past medical history included Asthma, mitral valve regurgitation, asymptomatic brain cavernoma, high blood pressure. The patients known allergies: PCN, Sulfa, iodine contrast and chocolate. The patient had COVID prior to vaccination. The concomitant medications included Synthroid 88, verapamil, Coreg, calcium/D and zinc. The patient did not have any other vaccines in four weeks. On 19Feb2021, at 12:00AM the patient experienced Slightly sore arm. The clinical outcome for slightly sore arm was recovered.  Information about lot/Batch number has been requested.
Red rash with white center. Patient states the rash has changed shape and size several times. She says it is bigger today and has some heat. Patient states she does not have a fever. She has been taking benadryl, ibuprofen, and using compresses after our recommendation on Sunday but rash is not getting better. This is day 6  so we told her to add hydro-cortisone cream tonight and if no better by tomorrow to seek treatment.
Bad fever, pain, localized, redness in upper bicep that spread almost to outer elbow and into the inside of bicep. Muscle weakness and hot to the touch and could see redness.
J96.00 ACUTE RESPIRATORY FAILURE 6/18/2022 PNEUMONIA
Developed severe hives on April 18th (large red bumps, size of quarter to golf ball). Developed on left arm pit, back of head, tummy and elbows. Went to urgent care on morning of April 19th, received 7 day steroids. Told to wait to see how the steroids work. If the hives get worse, was instructed to go to the ER.
nose bleeds; diarrhea; muscle ache; body aches; sore throat; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (nose bleeds), DIARRHOEA (diarrhea), MYALGIA (muscle ache), MYALGIA (body aches) and OROPHARYNGEAL PAIN (sore throat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EPISTAXIS (nose bleeds), DIARRHOEA (diarrhea), MYALGIA (muscle ache), MYALGIA (body aches), OROPHARYNGEAL PAIN (sore throat) and VOMITING (vomiting). At the time of the report, EPISTAXIS (nose bleeds), DIARRHOEA (diarrhea), MYALGIA (muscle ache), MYALGIA (body aches), OROPHARYNGEAL PAIN (sore throat) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  No treatment details were provided.
AFTER VAX, EXP INCREASED LIVER ENZYMES, JAUNDICE, AND MALAISE.  TX & OUTCOME UNKNOWN.  3 wks p/ receiving vax, pt dev hepatitis (bili = 4.9).  Testing for Hep A,B,C was neg.  Sx resolved w/o tmt.
Tingly feeling in both her hands/sometimes in her feet; Tingly feeling in her tongue; This spontaneous case was reported by a patient and describes the occurrence of PARAESTHESIA (Tingly feeling in both her hands/sometimes in her feet) and PARAESTHESIA ORAL (Tingly feeling in her tongue) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was provided.  Concomitant products included ACETAMINOPHEN and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced PARAESTHESIA (Tingly feeling in both her hands/sometimes in her feet) and PARAESTHESIA ORAL (Tingly feeling in her tongue). At the time of the report, PARAESTHESIA (Tingly feeling in both her hands/sometimes in her feet) and PARAESTHESIA ORAL (Tingly feeling in her tongue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   Reporter did not allow further contact
extreme pain in arm receiving vaccine.  to the point where I could not lift it.  It exacerbated my tennis elbow to a pain level 10.  arm hurt even at rest. It did not return to any sense of normal until day 3. OUCH
p/vax pt w/a prev inj site rxn;pt exp inj site rxn;pt sought unspecified medical attention;a couple of days p/vax pt recovered;
pt recvd 2 doses of MMR vax approx 20-30 yrs ago & lab eval revealed neg titers; pt was revaxed & then tested pos to rubella; The nurse reported 2 pts;
Client presented to  Center on 09/26/2022 requesting Novavax vaccine. Client did not have COVID vaccine card with her. Ancillary staff verified client's vaccine record and verified that client had received 3 previous doses of Moderna vaccine. Notified RN that client is requesting Novavax vaccine but has had previous Moderna doses already. RN told ancillary staff that Novavax is only for primary series. RN called client to vaccination room. Client verified identification, stated NKA, and stated history of "weakened immune system with chronic leukemia." Client stated she is here for Novavax vaccine, and did not have a COVID vaccine card as she denied having received previous COVID vaccines. Client educated that Novavax vaccine is for individuals who have not previously received a COVID vaccine, and notified of emergency protocol to call 911 or go to hospital for any serious allergic reactions after vaccination. After client denied previous COVID vaccines, RN administered Novavax COVID vaccine lot # 4302MF023 on 09/26/2022 at 3:28pm. Client did not wait 15 minutes after vaccination, and left vaccination site with steady gait. Ancillary staff notified RN that client had previous COVID doses on record. RN notified Clinical Project Coordinator of incident, and instructed RN to notify on-call doctor and complete Incident Report, VAERS. RN notified on-call doctor via text message. Per on-call doctor, no further recommendations given, and 15-minute observation period is recommended but not mandated.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions and concomitant therapies was provided. On an unknown date in 2016, the patient was vaccinated with the second dose of RECOMBIVAX HB injection (dose, route of administration, lot # and expiry date were not reported. On 26-OCT-2016, less than four months following the second dose, the patient was vaccinated with the third dose of RECOMBIVAX HB injection (lot#, expiration date, dose and route of administration were not reported) (no information regarding the first dose of the vaccine was provided). No adverse effect was reported. There was no product quality complaint involved. Additional information is not expected because there was no consent for follow-up.
She received the vaccine, had not issues and then approximately 5-6 days later started with tinnitus, chirping/crickets in her ears.  She had never had ringing in her ears in the past, and it has not diminished since having this.  It is worse when she is in a quiet room.